Glaucoma News

Using artificial intelligence to identify central visual field loss patterns better predicted quality of life impairment in patients with glaucoma compared with using central visual field mean deviation alone, according to findings from a retrospective study.

The recent paradigm shift in the treatment of glaucoma moving toward earlier intervention, better managing patient compliance and a refocus on addressing the actual pathology continues to move forward with the approval of Durysta, a 10 µg bimatoprost implant for intracameral administration.

Patients with glaucoma showed significant reduction in the occipital pole surface area in the left and right hemispheres, according to a cross-sectional study published in the Journal of Glaucoma.

IOP screening may improve detection rates of glaucoma among a younger population and increase awareness of the disease, according to findings from a recent study.

ORLANDO — At Cataract Surgery: Telling It Like It Is, Inder Paul Singh, MD, discusses the importance of introducing MIGS into practices.

WASHINGTON — The use of digital fundus photography in a newly designed model of a Pondicherry eye screening camp better improved case detection, referral and follow-up rates for posterior segment diseases such as glaucoma, according to a speaker here.

WASHINGTON — Patients who better adhered to topical glaucoma medications over time experienced a slower rate of visual field decline compared with patients with poor adherence to their medications, according to a speaker here.

Researchers based in the Netherlands, Australia, the U.K. and the U.S. reported that there was no genetic correlation between myopia and primary open-angle glaucoma.

WASHINGTON — Two conventional machine learning algorithms and two convolutional neural network models achieved high glaucoma diagnostic performances by reading full retinal nerve fiber layer thickness maps, according to a speaker here.

MARRAKECH, Morocco — At the European Society of Cataract and Refractive Surgeons Winter Meeting, Simonetta Morselli, MD, shares her experience with the Xen gel stent (Allergan). She is one of the investigators in a European study evaluating the safety and efficacy of the new Xen 63 and explains what differentiates this option from the previous Xen 45.